<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Vaccines &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/vaccines/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 14:01:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Vaccines &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Advantages of intranasal vaccination against SARS-CoV-2</title>
		<link>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/</link>
					<comments>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 17:40:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/</guid>

					<description><![CDATA[Intranasal vaccination is needle-free and elicits immunity at the site of infection, the respiratory tract Credit: UAB BIRMINGHAM, Ala. &#8211; There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174491</post-id>	</item>
		<item>
		<title>New insights into immune responses to malaria</title>
		<link>https://bioengineer.org/new-insights-into-immune-responses-to-malaria/</link>
					<comments>https://bioengineer.org/new-insights-into-immune-responses-to-malaria/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 14:49:28 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Algorithms/Models]]></category>
		<category><![CDATA[Disease in the Developing World]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Mathematics/Statistics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-insights-into-immune-responses-to-malaria/</guid>

					<description><![CDATA[Credit: WEHI, Australia Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically. An international team used mass cytometry &#8211; an in-depth way of characterising individual cells &#8211; and machine learning to discover &#8216;immune [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/new-insights-into-immune-responses-to-malaria/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174469</post-id>	</item>
		<item>
		<title>Virginia Tech&#8217;s COVID-19 testing demonstrates power, versatility of academic labs</title>
		<link>https://bioengineer.org/virginia-techs-covid-19-testing-demonstrates-power-versatility-of-academic-labs/</link>
					<comments>https://bioengineer.org/virginia-techs-covid-19-testing-demonstrates-power-versatility-of-academic-labs/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jul 2021 21:25:29 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Genes]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/virginia-techs-covid-19-testing-demonstrates-power-versatility-of-academic-labs/</guid>

					<description><![CDATA[Credit: Clayton Metz/Virginia Tech In the early days of the pandemic, scientists at Virginia Tech created a COVID-19 testing laboratory and novel test for the virus from scratch. They not only developed a test in-house that avoided the reagent supply shortages that hampered testing efforts nationwide, but also used 3D-engineered supplies and stable storage media, [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/virginia-techs-covid-19-testing-demonstrates-power-versatility-of-academic-labs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174190</post-id>	</item>
		<item>
		<title>Public trust in CDC, FDA, and Fauci holds steady, survey shows</title>
		<link>https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/</link>
					<comments>https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jul 2021 17:59:28 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Behavior]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Mass Media]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Mental Health]]></category>
		<category><![CDATA[Perception/Awareness]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/</guid>

					<description><![CDATA[But heavy users of conservative media have less confidence and are more likely to believe in conspiracy theories Credit: Annenberg Public Policy Center of the University of Pennsylvania With more than two-thirds of American adults vaccinated with at least one dose of an authorized Covid-19 vaccine, the top U.S. health agencies retain the trust of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174170</post-id>	</item>
		<item>
		<title>Take your best shot: Which SARS-CoV-2 vaccine should I get, if any?</title>
		<link>https://bioengineer.org/take-your-best-shot-which-sars-cov-2-vaccine-should-i-get-if-any/</link>
					<comments>https://bioengineer.org/take-your-best-shot-which-sars-cov-2-vaccine-should-i-get-if-any/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jul 2021 16:59:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Decision-making/Problem Solving]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Mental Health]]></category>
		<category><![CDATA[Minorities]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Quality of Life]]></category>
		<category><![CDATA[Stress/Anxiety]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/take-your-best-shot-which-sars-cov-2-vaccine-should-i-get-if-any/</guid>

					<description><![CDATA[University of Cincinnati physician-researcher uses computerized decision model to provide evidence that being vaccinated is better than not Credit: Colleen Kelley/University of Cincinnati Vaccine hesitancy continues to be a hurdle in the development of widespread immunity within the U.S. population as the COVID-19 pandemic enters its second year. Researchers at the University of Cincinnati College [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/take-your-best-shot-which-sars-cov-2-vaccine-should-i-get-if-any/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174160</post-id>	</item>
		<item>
		<title>SARS-CoV-2 spike mutation L452R evades human immune response and enhances infectivity</title>
		<link>https://bioengineer.org/sars-cov-2-spike-mutation-l452r-evades-human-immune-response-and-enhances-infectivity/</link>
					<comments>https://bioengineer.org/sars-cov-2-spike-mutation-l452r-evades-human-immune-response-and-enhances-infectivity/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jul 2021 14:41:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Physiology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/sars-cov-2-spike-mutation-l452r-evades-human-immune-response-and-enhances-infectivity/</guid>

					<description><![CDATA[Credit: Dr. Chihiro Motozono An international team of researchers led by Kumamoto and Tokyo Universities (Japan) have shown that the L452R mutation of the SARS-CoV-2 spike protein, which is common to two mutant strains (Epsilon and Delta), is involved in cellular immunity evasion via the human leukocyte antigen (HLA) A24, and enhances viral infectivity. HLA-A24 [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/sars-cov-2-spike-mutation-l452r-evades-human-immune-response-and-enhances-infectivity/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174118</post-id>	</item>
		<item>
		<title>Study finds vaccine hesitancy lower in poorer countries</title>
		<link>https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/</link>
					<comments>https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jul 2021 19:10:21 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[Disease in the Developing World]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medical/Scientific Ethics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/</guid>

					<description><![CDATA[New study examines vaccine acceptance and hesitancy in 10 low- and middle-income countries in Asia, Africa, and South America Credit: Fadil Fauzi New research published in Nature Medicine reveals willingness to get a COVID-19 vaccine was considerably higher in developing countries (80% of respondents) than in the United States (65%) and Russia (30%). The study [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173969</post-id>	</item>
		<item>
		<title>Allocating COVID vaccines based on health and socioeconomic factors could cut mortality</title>
		<link>https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/</link>
					<comments>https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 19:07:06 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Socioeconomics]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/</guid>

					<description><![CDATA[Study suggests spatial relationship between COVID-19 mortality and population-level health factors Credit: Kandula S and Shaman J, 2021, PLOS Medicine, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) An estimated 43 percent of the variability in U.S. COVID-19 mortality is linked with county-level socioeconomic indicators and health vulnerabilities, with the strongest association seen in the proportions of people living with [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173679</post-id>	</item>
		<item>
		<title>Allocating COVID-19 vaccines based on health and socioeconomics could reduce mortality</title>
		<link>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/</link>
					<comments>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 19:00:02 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/</guid>

					<description><![CDATA[Study suggests spatial relationship between COVID-19 mortality and population-level health factors Credit: Kandula S and Shaman J, 2021, PLOS Medicine COVID-19 vaccination strategies in the United States are informed by individual characteristics such as age and occupation. A study published in the open access journal PLOS Medicine by Sasikiran Kandula and Jeffrey Shaman of Columbia [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173677</post-id>	</item>
		<item>
		<title>One shot of the Sputnik V vaccine triggers strong antibody responses</title>
		<link>https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/</link>
					<comments>https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 16:58:37 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/</guid>

					<description><![CDATA[Credit: Rossi and Ojeda et al./Cell Reports Medicine A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine. &#8220;Due to limited vaccine supply and uneven vaccine distribution in many regions of the world, health authorities urgently need data [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173665</post-id>	</item>
		<item>
		<title>COVID-causing coronavirus following predictable mutational footsteps</title>
		<link>https://bioengineer.org/covid-causing-coronavirus-following-predictable-mutational-footsteps/</link>
					<comments>https://bioengineer.org/covid-causing-coronavirus-following-predictable-mutational-footsteps/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 16:21:02 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Evolution]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/covid-causing-coronavirus-following-predictable-mutational-footsteps/</guid>

					<description><![CDATA[Similarities in locations, types of mutations could inform responses to future SARS-CoV-2 strains Credit: Scott Schrage, University of Nebraska-Lincoln New research from the University of Nebraska-Lincoln has shown that the mutations arising in the COVID-19-causing SARS-CoV-2 virus seem to run in the family &#8212; or at least the genus of coronaviruses most dangerous to humans. [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/covid-causing-coronavirus-following-predictable-mutational-footsteps/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173651</post-id>	</item>
		<item>
		<title>Why we need to talk openly about vaccine side effects</title>
		<link>https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/</link>
					<comments>https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 16:10:40 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Behavior]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Language/Linguistics/Speech]]></category>
		<category><![CDATA[Mass Media]]></category>
		<category><![CDATA[Medical/Scientific Ethics]]></category>
		<category><![CDATA[Political Science]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/</guid>

					<description><![CDATA[We need to talk openly about vaccine side effects if we are to defeat the coronavirus pandemic Credit: Aarhus University Concerns have been raised about the AstraZeneca and Johnson &#038; Johnson vaccines regarding very rare but potentially fatal side effects related to low blood platelet counts and blood clots. Recently, reports also emerged that the [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173361</post-id>	</item>
		<item>
		<title>McMaster researchers identify how VITT happens</title>
		<link>https://bioengineer.org/mcmaster-researchers-identify-how-vitt-happens/</link>
					<comments>https://bioengineer.org/mcmaster-researchers-identify-how-vitt-happens/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jul 2021 14:37:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Hematology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mcmaster-researchers-identify-how-vitt-happens/</guid>

					<description><![CDATA[The work will have both diagnostic and therapeutic implications Credit: James Smith/McMaster University Hamilton, ON (July 7, 2021) &#8211; A McMaster University team of researchers recently discovered how, exactly, the COVID-19 vaccines that use adenovirus vectors trigger a rare but sometimes fatal blood clotting reaction called vaccine-induced immune thrombotic thrombocytopenia or VITT. The findings will [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/mcmaster-researchers-identify-how-vitt-happens/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173220</post-id>	</item>
		<item>
		<title>COVID gets quantum treatment for drug discovery</title>
		<link>https://bioengineer.org/covid-gets-quantum-treatment-for-drug-discovery/</link>
					<comments>https://bioengineer.org/covid-gets-quantum-treatment-for-drug-discovery/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jul 2021 14:58:27 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Computer Science]]></category>
		<category><![CDATA[Hardware]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/covid-gets-quantum-treatment-for-drug-discovery/</guid>

					<description><![CDATA[Oak Ridge National Laboratory researchers use Stampede2 to refine drug discovery pipeline Credit: TACC Since the first known case of COVID-19 in December 2019, the disease has infected over 180 million people and killed nearly four million. A successful group of vaccines that target the coronavirus&#8217;s spike protein has started to drive down global infection. Supercomputers are [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/covid-gets-quantum-treatment-for-drug-discovery/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173035</post-id>	</item>
		<item>
		<title>Study shows laboratory developed protein spikes consistent with COVID-19 virus</title>
		<link>https://bioengineer.org/study-shows-laboratory-developed-protein-spikes-consistent-with-covid-19-virus/</link>
					<comments>https://bioengineer.org/study-shows-laboratory-developed-protein-spikes-consistent-with-covid-19-virus/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jul 2021 14:55:24 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-shows-laboratory-developed-protein-spikes-consistent-with-covid-19-virus/</guid>

					<description><![CDATA[Credit: University of Southampton A new international study has found that the key properties of the spikes of SARS-CoV-2 virus which causes COVID-19 are consistent with those of several laboratory-developed protein spikes, designed to mimic the infectious virus. A central component in designing serological tests and vaccines to protect against COVID-19 is the manufacture of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-shows-laboratory-developed-protein-spikes-consistent-with-covid-19-virus/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173031</post-id>	</item>
		<item>
		<title>For transplant patients, COVID-19 vaccination presents a different uncertainty</title>
		<link>https://bioengineer.org/for-transplant-patients-covid-19-vaccination-presents-a-different-uncertainty/</link>
					<comments>https://bioengineer.org/for-transplant-patients-covid-19-vaccination-presents-a-different-uncertainty/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 01 Jul 2021 18:44:56 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Transplantation]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/for-transplant-patients-covid-19-vaccination-presents-a-different-uncertainty/</guid>

					<description><![CDATA[A pair of clinical trials at UC San Diego Health and Altman Clinical and Translational Research Institute seek to quantify vaccine benefit to immunocompromised patients &#8212; and perhaps help improve it Credit: UC San Diego Health Sciences Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/for-transplant-patients-covid-19-vaccination-presents-a-different-uncertainty/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172917</post-id>	</item>
		<item>
		<title>Investigational malaria vaccine gives strong, lasting protection</title>
		<link>https://bioengineer.org/investigational-malaria-vaccine-gives-strong-lasting-protection/</link>
					<comments>https://bioengineer.org/investigational-malaria-vaccine-gives-strong-lasting-protection/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 30 Jun 2021 15:36:15 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Disease in the Developing World]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/investigational-malaria-vaccine-gives-strong-lasting-protection/</guid>

					<description><![CDATA[Phase 1 trials conducted at NIH Clinical Center Credit: NIAID WHAT: Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. The vaccine combines live parasites with either of two widely used [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/investigational-malaria-vaccine-gives-strong-lasting-protection/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172801</post-id>	</item>
		<item>
		<title>Studying how microbiome affects immunity could improve vaccine effectiveness</title>
		<link>https://bioengineer.org/studying-how-microbiome-affects-immunity-could-improve-vaccine-effectiveness/</link>
					<comments>https://bioengineer.org/studying-how-microbiome-affects-immunity-could-improve-vaccine-effectiveness/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 29 Jun 2021 17:35:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bacteriology]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/studying-how-microbiome-affects-immunity-could-improve-vaccine-effectiveness/</guid>

					<description><![CDATA[AMES, Iowa &#8211; So many microbes live in and on your body that it might be helpful to think of them functioning collectively as a separate organ. That&#8217;s because these tiny organisms that live primarily in our gut, collectively known as the microbiome, often perform helpful functions that keep the body running smoothly. Scientists at [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/studying-how-microbiome-affects-immunity-could-improve-vaccine-effectiveness/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172753</post-id>	</item>
		<item>
		<title>Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection</title>
		<link>https://bioengineer.org/blood-clots-related-to-astrazeneca-oxford-vaccine-can-be-mitigated-with-early-detection/</link>
					<comments>https://bioengineer.org/blood-clots-related-to-astrazeneca-oxford-vaccine-can-be-mitigated-with-early-detection/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 29 Jun 2021 16:06:34 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Critical Care/Emergency Medicine]]></category>
		<category><![CDATA[Health Professionals]]></category>
		<category><![CDATA[Hematology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/blood-clots-related-to-astrazeneca-oxford-vaccine-can-be-mitigated-with-early-detection/</guid>

					<description><![CDATA[New research highlights the need for heightened awareness and early testing for patients with signs of clotting disorder following vaccination Tuesday, 29 June 2021 &#8211; New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to them being treated successfully, highlighting the need for heightened awareness [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/blood-clots-related-to-astrazeneca-oxford-vaccine-can-be-mitigated-with-early-detection/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172725</post-id>	</item>
		<item>
		<title>Researchers discover unique &#8216;spider web&#8217; mechanism that traps, kills viruses</title>
		<link>https://bioengineer.org/researchers-discover-unique-spider-web-mechanism-that-traps-kills-viruses/</link>
					<comments>https://bioengineer.org/researchers-discover-unique-spider-web-mechanism-that-traps-kills-viruses/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 29 Jun 2021 04:33:33 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/researchers-discover-unique-spider-web-mechanism-that-traps-kills-viruses/</guid>

					<description><![CDATA[Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19. The researchers have found that neutrophils, the most abundant white blood cells in the human body, explode when they bind to such pathogens coated in [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/researchers-discover-unique-spider-web-mechanism-that-traps-kills-viruses/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172665</post-id>	</item>
	</channel>
</rss>
